| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.45 | 0.004 |